Filing Details

Accession Number:
0001719842-18-000010
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-01 16:13:14
Reporting Period:
2018-07-30
Accepted Time:
2018-08-01 16:13:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1710155 National Vision Holdings Inc. EYE Ophthalmic Goods (3851) 464841717
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1719842 John Vaught C/O National Vision Holdings, Inc.
2435 Commerce Avenue, Bldg. 2200
Duluth GA 30096-4980
Svp, Chief Information Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-07-30 14,239 $38.26 2,164 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2018-07-30 35,244 $4.27 35,244 $4.27
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
48,670 2024-03-13 No 4 A Direct
Footnotes
  1. This amount represents the secondary public offering price per share of common stock of National Vision Holdings, Inc. of $39.75, less the underwriting discount of $1.4906 per share.
  2. On March 13, 2014, the reporting person was granted stock options, subject to time-based and performance-based vesting. On July 30, 2018, a liquidity event with respect to such performance-based stock options occurred as a result of sales by the Issuer's sponsor stockholders and 35,244 stock options which had previously not been reported were deemed earned.
  3. Of the 48,670 stock options reported herein, 35,244 are vested and the remaining 13,428 time-based stock options will vest on March 13, 2019. An additional 65,454 stock options which remain subject to liquidity-event performance-based vesting conditions are not included in the table above.